nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—atherosclerosis	0.328	0.529	CbGaD
Bismuth Subsalicylate—ALB—atherosclerosis	0.293	0.471	CbGaD
Bismuth Subsalicylate—ALB—Rosuvastatin—atherosclerosis	0.0541	1	CbGbCtD
Bismuth Subsalicylate—TF—blood vessel—atherosclerosis	0.00605	0.136	CbGeAlD
Bismuth Subsalicylate—PTGS2—leg—atherosclerosis	0.00402	0.0904	CbGeAlD
Bismuth Subsalicylate—PTGS2—hindlimb—atherosclerosis	0.00359	0.0807	CbGeAlD
Bismuth Subsalicylate—Upset stomach—Lovastatin—atherosclerosis	0.00338	0.0318	CcSEcCtD
Bismuth Subsalicylate—Upset stomach—Simvastatin—atherosclerosis	0.00316	0.0298	CcSEcCtD
Bismuth Subsalicylate—TF—connective tissue—atherosclerosis	0.0031	0.0697	CbGeAlD
Bismuth Subsalicylate—PTGS2—appendage—atherosclerosis	0.00308	0.0692	CbGeAlD
Bismuth Subsalicylate—Heartburn—Niacin—atherosclerosis	0.00276	0.026	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Niacin—atherosclerosis	0.00273	0.0258	CcSEcCtD
Bismuth Subsalicylate—Heartburn—Pravastatin—atherosclerosis	0.00272	0.0256	CcSEcCtD
Bismuth Subsalicylate—TF—cardiovascular system—atherosclerosis	0.0027	0.0607	CbGeAlD
Bismuth Subsalicylate—Lung disorder—Niacin—atherosclerosis	0.00268	0.0253	CcSEcCtD
Bismuth Subsalicylate—TF—adipose tissue—atherosclerosis	0.00238	0.0535	CbGeAlD
Bismuth Subsalicylate—PTGS1—artery—atherosclerosis	0.0023	0.0518	CbGeAlD
Bismuth Subsalicylate—PTGS2—artery—atherosclerosis	0.0022	0.0495	CbGeAlD
Bismuth Subsalicylate—Hearing impaired—Pravastatin—atherosclerosis	0.00197	0.0185	CcSEcCtD
Bismuth Subsalicylate—PTGS1—endothelium—atherosclerosis	0.00194	0.0437	CbGeAlD
Bismuth Subsalicylate—PTGS2—endothelium—atherosclerosis	0.00186	0.0418	CbGeAlD
Bismuth Subsalicylate—Skin exfoliation—Niacin—atherosclerosis	0.00181	0.0171	CcSEcCtD
Bismuth Subsalicylate—PTGS1—blood vessel—atherosclerosis	0.00179	0.0403	CbGeAlD
Bismuth Subsalicylate—Oesophagitis—Niacin—atherosclerosis	0.00174	0.0164	CcSEcCtD
Bismuth Subsalicylate—PTGS2—blood vessel—atherosclerosis	0.00171	0.0385	CbGeAlD
Bismuth Subsalicylate—TF—liver—atherosclerosis	0.00167	0.0375	CbGeAlD
Bismuth Subsalicylate—Deafness—Pravastatin—atherosclerosis	0.00152	0.0143	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Lovastatin—atherosclerosis	0.00133	0.0125	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Rosuvastatin—atherosclerosis	0.00131	0.0124	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Simvastatin—atherosclerosis	0.00124	0.0117	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Lovastatin—atherosclerosis	0.00111	0.0105	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Ezetimibe—atherosclerosis	0.00109	0.0103	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Pravastatin—atherosclerosis	0.00107	0.0101	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Lovastatin—atherosclerosis	0.00105	0.0099	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Simvastatin—atherosclerosis	0.00104	0.00979	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Ezetimibe—atherosclerosis	0.00103	0.00971	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Simvastatin—atherosclerosis	0.000982	0.00926	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Niacin—atherosclerosis	0.000954	0.00899	CcSEcCtD
Bismuth Subsalicylate—Erythema—Ezetimibe—atherosclerosis	0.000948	0.00894	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Lovastatin—atherosclerosis	0.000947	0.00893	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Pravastatin—atherosclerosis	0.000939	0.00885	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Rosuvastatin—atherosclerosis	0.000939	0.00885	CcSEcCtD
Bismuth Subsalicylate—Infection—Rosuvastatin—atherosclerosis	0.000925	0.00872	CcSEcCtD
Bismuth Subsalicylate—PTGS1—connective tissue—atherosclerosis	0.000919	0.0207	CbGeAlD
Bismuth Subsalicylate—Erythema—Simvastatin—atherosclerosis	0.000905	0.00853	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Niacin—atherosclerosis	0.00089	0.00838	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Pravastatin—atherosclerosis	0.000888	0.00837	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Simvastatin—atherosclerosis	0.000886	0.00835	CcSEcCtD
Bismuth Subsalicylate—PTGS2—connective tissue—atherosclerosis	0.000879	0.0198	CbGeAlD
Bismuth Subsalicylate—Tinnitus—Pravastatin—atherosclerosis	0.000876	0.00826	CcSEcCtD
Bismuth Subsalicylate—ALB—liver—atherosclerosis	0.000868	0.0195	CbGeAlD
Bismuth Subsalicylate—Erythema—Niacin—atherosclerosis	0.000831	0.00783	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00082	0.00773	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Pravastatin—atherosclerosis	0.000801	0.00755	CcSEcCtD
Bismuth Subsalicylate—PTGS1—cardiovascular system—atherosclerosis	0.0008	0.018	CbGeAlD
Bismuth Subsalicylate—Pain—Rosuvastatin—atherosclerosis	0.000796	0.00751	CcSEcCtD
Bismuth Subsalicylate—Constipation—Rosuvastatin—atherosclerosis	0.000796	0.00751	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Lovastatin—atherosclerosis	0.000796	0.0075	CcSEcCtD
Bismuth Subsalicylate—Infection—Lovastatin—atherosclerosis	0.000784	0.00739	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Ezetimibe—atherosclerosis	0.000781	0.00736	CcSEcCtD
Bismuth Subsalicylate—Infection—Ezetimibe—atherosclerosis	0.000769	0.00725	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000767	0.00723	CcSEcCtD
Bismuth Subsalicylate—PTGS2—cardiovascular system—atherosclerosis	0.000765	0.0172	CbGeAlD
Bismuth Subsalicylate—Anorexia—Lovastatin—atherosclerosis	0.000752	0.00709	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Simvastatin—atherosclerosis	0.000744	0.00702	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Rosuvastatin—atherosclerosis	0.00074	0.00697	CcSEcCtD
Bismuth Subsalicylate—Oedema—Simvastatin—atherosclerosis	0.000738	0.00696	CcSEcCtD
Bismuth Subsalicylate—Infection—Simvastatin—atherosclerosis	0.000733	0.00691	CcSEcCtD
Bismuth Subsalicylate—PTGS1—adipose tissue—atherosclerosis	0.000705	0.0159	CbGeAlD
Bismuth Subsalicylate—Anorexia—Simvastatin—atherosclerosis	0.000704	0.00663	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Lovastatin—atherosclerosis	0.000695	0.00655	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Lovastatin—atherosclerosis	0.000686	0.00647	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Ezetimibe—atherosclerosis	0.000681	0.00642	CcSEcCtD
Bismuth Subsalicylate—Oedema—Niacin—atherosclerosis	0.000678	0.00639	CcSEcCtD
Bismuth Subsalicylate—Constipation—Lovastatin—atherosclerosis	0.000675	0.00636	CcSEcCtD
Bismuth Subsalicylate—Pain—Lovastatin—atherosclerosis	0.000675	0.00636	CcSEcCtD
Bismuth Subsalicylate—PTGS2—adipose tissue—atherosclerosis	0.000674	0.0152	CbGeAlD
Bismuth Subsalicylate—Confusional state—Pravastatin—atherosclerosis	0.000673	0.00634	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Ezetimibe—atherosclerosis	0.000673	0.00634	CcSEcCtD
Bismuth Subsalicylate—Oedema—Pravastatin—atherosclerosis	0.000667	0.00629	CcSEcCtD
Bismuth Subsalicylate—Infection—Pravastatin—atherosclerosis	0.000663	0.00625	CcSEcCtD
Bismuth Subsalicylate—Pain—Ezetimibe—atherosclerosis	0.000662	0.00624	CcSEcCtD
Bismuth Subsalicylate—Constipation—Ezetimibe—atherosclerosis	0.000662	0.00624	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Rosuvastatin—atherosclerosis	0.000659	0.00621	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Lovastatin—atherosclerosis	0.00065	0.00613	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Simvastatin—atherosclerosis	0.00065	0.00612	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Niacin—atherosclerosis	0.000646	0.00609	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Simvastatin—atherosclerosis	0.000642	0.00605	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Ezetimibe—atherosclerosis	0.000638	0.00601	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000637	0.00601	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Pravastatin—atherosclerosis	0.000636	0.006	CcSEcCtD
Bismuth Subsalicylate—Pain—Simvastatin—atherosclerosis	0.000631	0.00595	CcSEcCtD
Bismuth Subsalicylate—Constipation—Simvastatin—atherosclerosis	0.000631	0.00595	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Lovastatin—atherosclerosis	0.000627	0.00591	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Lovastatin—atherosclerosis	0.000624	0.00588	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Rosuvastatin—atherosclerosis	0.000616	0.0058	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Ezetimibe—atherosclerosis	0.000615	0.0058	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Ezetimibe—atherosclerosis	0.000612	0.00577	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Simvastatin—atherosclerosis	0.000608	0.00573	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Niacin—atherosclerosis	0.000603	0.00568	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Niacin—atherosclerosis	0.000597	0.00562	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Niacin—atherosclerosis	0.000589	0.00555	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Pravastatin—atherosclerosis	0.000587	0.00554	CcSEcCtD
Bismuth Subsalicylate—Rash—Rosuvastatin—atherosclerosis	0.000587	0.00553	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Rosuvastatin—atherosclerosis	0.000587	0.00553	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Simvastatin—atherosclerosis	0.000586	0.00553	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Simvastatin—atherosclerosis	0.000584	0.0055	CcSEcCtD
Bismuth Subsalicylate—Headache—Rosuvastatin—atherosclerosis	0.000583	0.0055	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Pravastatin—atherosclerosis	0.00058	0.00547	CcSEcCtD
Bismuth Subsalicylate—Pain—Niacin—atherosclerosis	0.00058	0.00546	CcSEcCtD
Bismuth Subsalicylate—Constipation—Pravastatin—atherosclerosis	0.000571	0.00538	CcSEcCtD
Bismuth Subsalicylate—Pain—Pravastatin—atherosclerosis	0.000571	0.00538	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Lovastatin—atherosclerosis	0.000558	0.00526	CcSEcCtD
Bismuth Subsalicylate—Nausea—Rosuvastatin—atherosclerosis	0.000553	0.00521	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Pravastatin—atherosclerosis	0.00055	0.00518	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Ezetimibe—atherosclerosis	0.000548	0.00516	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Lovastatin—atherosclerosis	0.00054	0.00509	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Niacin—atherosclerosis	0.000538	0.00508	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Niacin—atherosclerosis	0.000536	0.00505	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Pravastatin—atherosclerosis	0.00053	0.005	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Ezetimibe—atherosclerosis	0.00053	0.00499	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Pravastatin—atherosclerosis	0.000528	0.00497	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Simvastatin—atherosclerosis	0.000522	0.00492	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Lovastatin—atherosclerosis	0.000522	0.00492	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Ezetimibe—atherosclerosis	0.000512	0.00482	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Simvastatin—atherosclerosis	0.000505	0.00476	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Lovastatin—atherosclerosis	0.000502	0.00473	CcSEcCtD
Bismuth Subsalicylate—Rash—Lovastatin—atherosclerosis	0.000498	0.00469	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Lovastatin—atherosclerosis	0.000497	0.00469	CcSEcCtD
Bismuth Subsalicylate—Headache—Lovastatin—atherosclerosis	0.000494	0.00466	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Ezetimibe—atherosclerosis	0.000492	0.00464	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Simvastatin—atherosclerosis	0.000488	0.0046	CcSEcCtD
Bismuth Subsalicylate—Rash—Ezetimibe—atherosclerosis	0.000488	0.0046	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Ezetimibe—atherosclerosis	0.000488	0.0046	CcSEcCtD
Bismuth Subsalicylate—Headache—Ezetimibe—atherosclerosis	0.000485	0.00457	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Niacin—atherosclerosis	0.00048	0.00452	CcSEcCtD
Bismuth Subsalicylate—PTGS2—liver—atherosclerosis	0.000473	0.0106	CbGeAlD
Bismuth Subsalicylate—Pruritus—Pravastatin—atherosclerosis	0.000472	0.00445	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Simvastatin—atherosclerosis	0.000469	0.00442	CcSEcCtD
Bismuth Subsalicylate—Nausea—Lovastatin—atherosclerosis	0.000469	0.00442	CcSEcCtD
Bismuth Subsalicylate—Rash—Simvastatin—atherosclerosis	0.000465	0.00439	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Simvastatin—atherosclerosis	0.000465	0.00438	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Niacin—atherosclerosis	0.000464	0.00437	CcSEcCtD
Bismuth Subsalicylate—Headache—Simvastatin—atherosclerosis	0.000462	0.00436	CcSEcCtD
Bismuth Subsalicylate—Nausea—Ezetimibe—atherosclerosis	0.00046	0.00433	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Pravastatin—atherosclerosis	0.000457	0.0043	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Niacin—atherosclerosis	0.000448	0.00422	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Pravastatin—atherosclerosis	0.000441	0.00416	CcSEcCtD
Bismuth Subsalicylate—Nausea—Simvastatin—atherosclerosis	0.000438	0.00413	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Niacin—atherosclerosis	0.000431	0.00406	CcSEcCtD
Bismuth Subsalicylate—Rash—Niacin—atherosclerosis	0.000427	0.00403	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Niacin—atherosclerosis	0.000427	0.00402	CcSEcCtD
Bismuth Subsalicylate—Headache—Niacin—atherosclerosis	0.000425	0.004	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Pravastatin—atherosclerosis	0.000424	0.004	CcSEcCtD
Bismuth Subsalicylate—Rash—Pravastatin—atherosclerosis	0.000421	0.00397	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Pravastatin—atherosclerosis	0.00042	0.00396	CcSEcCtD
Bismuth Subsalicylate—Headache—Pravastatin—atherosclerosis	0.000418	0.00394	CcSEcCtD
Bismuth Subsalicylate—Nausea—Niacin—atherosclerosis	0.000403	0.00379	CcSEcCtD
Bismuth Subsalicylate—Nausea—Pravastatin—atherosclerosis	0.000396	0.00374	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—AKT1—atherosclerosis	4.65e-05	0.000267	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	4.61e-05	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	4.6e-05	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F7—atherosclerosis	4.59e-05	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP7A1—atherosclerosis	4.57e-05	0.000262	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	4.51e-05	0.000258	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	4.5e-05	0.000258	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOA4—atherosclerosis	4.41e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.38e-05	0.000251	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.36e-05	0.00025	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.35e-05	0.00025	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.32e-05	0.000248	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	4.31e-05	0.000247	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP27A1—atherosclerosis	4.22e-05	0.000242	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.22e-05	0.000242	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.21e-05	0.000241	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.16e-05	0.000239	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCG8—atherosclerosis	4.1e-05	0.000235	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LTA4H—atherosclerosis	4.1e-05	0.000235	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAT—atherosclerosis	4.09e-05	0.000234	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.06e-05	0.000233	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.04e-05	0.000232	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	4.02e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLA2G2A—atherosclerosis	4e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOA2—atherosclerosis	4e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALOX15—atherosclerosis	4e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALOX5AP—atherosclerosis	4e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCG1—atherosclerosis	4e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCG5—atherosclerosis	3.96e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.95e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	3.94e-05	0.000226	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.94e-05	0.000226	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.87e-05	0.000222	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LPA—atherosclerosis	3.82e-05	0.000219	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.82e-05	0.000219	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOA2—atherosclerosis	3.8e-05	0.000218	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—FABP4—atherosclerosis	3.76e-05	0.000216	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LCAT—atherosclerosis	3.76e-05	0.000216	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	3.74e-05	0.000215	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	3.72e-05	0.000213	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BGN—atherosclerosis	3.7e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA4—atherosclerosis	3.69e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.67e-05	0.000211	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOA5—atherosclerosis	3.66e-05	0.00021	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	3.64e-05	0.000209	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP7A1—atherosclerosis	3.63e-05	0.000208	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KNG1—atherosclerosis	3.59e-05	0.000206	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	3.58e-05	0.000205	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.56e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAUR—atherosclerosis	3.56e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.54e-05	0.000203	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLA2G1B—atherosclerosis	3.53e-05	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BGN—atherosclerosis	3.51e-05	0.000201	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.49e-05	0.0002	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLG—atherosclerosis	3.48e-05	0.000199	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.46e-05	0.000198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.45e-05	0.000198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.45e-05	0.000198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALOX5—atherosclerosis	3.41e-05	0.000195	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.4e-05	0.000195	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.38e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP27A1—atherosclerosis	3.35e-05	0.000192	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SOD1—atherosclerosis	3.33e-05	0.000191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.3e-05	0.000189	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.28e-05	0.000188	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCG1—atherosclerosis	3.24e-05	0.000186	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.22e-05	0.000185	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALOX5AP—atherosclerosis	3.18e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALOX15—atherosclerosis	3.18e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA2—atherosclerosis	3.18e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLA2G2A—atherosclerosis	3.18e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF2—atherosclerosis	3.17e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.15e-05	0.00018	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCG5—atherosclerosis	3.14e-05	0.00018	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.14e-05	0.00018	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APOB—atherosclerosis	3.07e-05	0.000176	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.07e-05	0.000176	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CST3—atherosclerosis	3.06e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NAMPT—atherosclerosis	3.05e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LCAT—atherosclerosis	3.04e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FABP4—atherosclerosis	3.04e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.04e-05	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LIPC—atherosclerosis	3.04e-05	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPA—atherosclerosis	3.03e-05	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOC3—atherosclerosis	3.02e-05	0.000173	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	3.01e-05	0.000173	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LDLR—atherosclerosis	3e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA4—atherosclerosis	2.99e-05	0.000171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BGN—atherosclerosis	2.94e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP7A1—atherosclerosis	2.94e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CETP—atherosclerosis	2.93e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.92e-05	0.000167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA5—atherosclerosis	2.91e-05	0.000167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NAMPT—atherosclerosis	2.9e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOC3—atherosclerosis	2.86e-05	0.000164	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PRKCG—atherosclerosis	2.85e-05	0.000164	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LDLR—atherosclerosis	2.84e-05	0.000163	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.82e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SCARB1—atherosclerosis	2.8e-05	0.000161	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLA2G1B—atherosclerosis	2.8e-05	0.000161	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.8e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CD36—atherosclerosis	2.79e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.78e-05	0.000159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.77e-05	0.000159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HSPA1B—atherosclerosis	2.74e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.74e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.74e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.73e-05	0.000157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP27A1—atherosclerosis	2.71e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALOX5—atherosclerosis	2.7e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.67e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	2.66e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NCF1—atherosclerosis	2.66e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMGCR—atherosclerosis	2.65e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.61e-05	0.000149	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	2.58e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLA2G2A—atherosclerosis	2.57e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA2—atherosclerosis	2.57e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALOX5AP—atherosclerosis	2.57e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALOX15—atherosclerosis	2.57e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PDGFB—atherosclerosis	2.57e-05	0.000147	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—atherosclerosis	2.54e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCG5—atherosclerosis	2.54e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.54e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CYBA—atherosclerosis	2.5e-05	0.000143	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.5e-05	0.000143	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPA—atherosclerosis	2.45e-05	0.000141	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PARP1—atherosclerosis	2.45e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CAV1—atherosclerosis	2.44e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	2.44e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APOA1—atherosclerosis	2.43e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NAMPT—atherosclerosis	2.42e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.41e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LIPC—atherosclerosis	2.41e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOC3—atherosclerosis	2.39e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.39e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LDLR—atherosclerosis	2.38e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BGN—atherosclerosis	2.38e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	2.36e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCA1—atherosclerosis	2.36e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.36e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA5—atherosclerosis	2.35e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CETP—atherosclerosis	2.32e-05	0.000133	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F2—atherosclerosis	2.32e-05	0.000133	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—atherosclerosis	2.29e-05	0.000131	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.29e-05	0.000131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.28e-05	0.000131	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLA2G1B—atherosclerosis	2.26e-05	0.00013	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.24e-05	0.000129	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.24e-05	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SCARB1—atherosclerosis	2.23e-05	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CG—atherosclerosis	2.22e-05	0.000127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.22e-05	0.000127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.21e-05	0.000127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALOX5—atherosclerosis	2.19e-05	0.000125	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.17e-05	0.000124	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.1e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMGCR—atherosclerosis	2.1e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF1—atherosclerosis	2.03e-05	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—atherosclerosis	2.03e-05	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.02e-05	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NAMPT—atherosclerosis	1.96e-05	0.000113	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.95e-05	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LIPC—atherosclerosis	1.95e-05	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOB—atherosclerosis	1.94e-05	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOC3—atherosclerosis	1.94e-05	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—atherosclerosis	1.93e-05	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LDLR—atherosclerosis	1.93e-05	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—atherosclerosis	1.89e-05	0.000108	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CETP—atherosclerosis	1.88e-05	0.000108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCA1—atherosclerosis	1.87e-05	0.000107	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LPL—atherosclerosis	1.85e-05	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—atherosclerosis	1.84e-05	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOB—atherosclerosis	1.84e-05	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPX1—atherosclerosis	1.81e-05	0.000104	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SCARB1—atherosclerosis	1.8e-05	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CD36—atherosclerosis	1.76e-05	0.000101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LPL—atherosclerosis	1.76e-05	0.000101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRKCG—atherosclerosis	1.71e-05	9.79e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMGCR—atherosclerosis	1.7e-05	9.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—atherosclerosis	1.67e-05	9.57e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.64e-05	9.42e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARA—atherosclerosis	1.64e-05	9.38e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—atherosclerosis	1.61e-05	9.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AGT—atherosclerosis	1.58e-05	9.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—atherosclerosis	1.58e-05	9.07e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOE—atherosclerosis	1.55e-05	8.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOB—atherosclerosis	1.54e-05	8.83e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PDGFB—atherosclerosis	1.54e-05	8.83e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAV1—atherosclerosis	1.54e-05	8.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOA1—atherosclerosis	1.53e-05	8.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.53e-05	8.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCA1—atherosclerosis	1.52e-05	8.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—atherosclerosis	1.5e-05	8.59e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOE—atherosclerosis	1.47e-05	8.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPL—atherosclerosis	1.47e-05	8.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CAV1—atherosclerosis	1.46e-05	8.36e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOA1—atherosclerosis	1.45e-05	8.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPX1—atherosclerosis	1.43e-05	8.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.4e-05	8.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CD36—atherosclerosis	1.4e-05	8.01e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—atherosclerosis	1.37e-05	7.87e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—atherosclerosis	1.35e-05	7.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—atherosclerosis	1.33e-05	7.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—INS—atherosclerosis	1.33e-05	7.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—atherosclerosis	1.32e-05	7.59e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—atherosclerosis	1.3e-05	7.46e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARA—atherosclerosis	1.3e-05	7.45e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AGT—atherosclerosis	1.26e-05	7.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—INS—atherosclerosis	1.26e-05	7.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK3—atherosclerosis	1.26e-05	7.2e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOB—atherosclerosis	1.25e-05	7.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOE—atherosclerosis	1.23e-05	7.07e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAV1—atherosclerosis	1.22e-05	7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA1—atherosclerosis	1.22e-05	6.99e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—atherosclerosis	1.22e-05	6.99e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—atherosclerosis	1.22e-05	6.97e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—atherosclerosis	1.21e-05	6.95e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPL—atherosclerosis	1.19e-05	6.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—atherosclerosis	1.16e-05	6.67e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX1—atherosclerosis	1.16e-05	6.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—atherosclerosis	1.15e-05	6.62e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CD36—atherosclerosis	1.13e-05	6.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.11e-05	6.38e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—atherosclerosis	1.1e-05	6.32e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—atherosclerosis	1.07e-05	6.16e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—atherosclerosis	1.07e-05	6.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—atherosclerosis	1.06e-05	6.1e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—INS—atherosclerosis	1.05e-05	6.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARA—atherosclerosis	1.05e-05	6.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AGT—atherosclerosis	1.02e-05	5.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOE—atherosclerosis	9.97e-06	5.72e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAV1—atherosclerosis	9.88e-06	5.67e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA1—atherosclerosis	9.86e-06	5.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—atherosclerosis	9.65e-06	5.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—atherosclerosis	9.23e-06	5.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CG—atherosclerosis	9e-06	5.16e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—atherosclerosis	8.69e-06	4.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—INS—atherosclerosis	8.52e-06	4.89e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—atherosclerosis	8.47e-06	4.86e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT3—atherosclerosis	7.86e-06	4.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK3—atherosclerosis	7.51e-06	4.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—atherosclerosis	7.47e-06	4.28e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—atherosclerosis	7.29e-06	4.18e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—atherosclerosis	6.83e-06	3.92e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—atherosclerosis	5.49e-06	3.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—atherosclerosis	5.35e-06	3.07e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—atherosclerosis	5.07e-06	2.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—atherosclerosis	4.24e-06	2.43e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—atherosclerosis	3.43e-06	1.97e-05	CbGpPWpGaD
